Thursday, May 26, 2022

Latest:

Research Spotlight: Dr. Fritz Sedlazeck assists in filling gaps in human genome, sequencing Rice University owl genome and more
Building community in Transition Medicine
Molecular profiling identifies new high-risk subtype of pediatric liver cancer
Celebrating Baylor College of Medicine Graduation 2022
Store food safely to avoid getting sick

Baylor College of Medicine Blog Network

Blog Network
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

cancer transcriptomics

From The Labs

Proteomics analysis identifies potential drug targets for aggressive human cancers

March 4, 2021March 4, 2021agrressive cancer, cancer proteomics, cancer therapy, cancer transcriptomics, Research

Researchers identified proteomic signatures associated with clinical measures of aggressive disease for each of the seven cancer types studied.

From the Labs: A closer look at tertiary lymphoid structures. Image courtesy of M. Zelazowski/ P. Castro/Baylor’s Human Tissue Acquisition & Pathology (HTAP) Core.